A Laboratory Model for Heroin Abuse Medications - 8 - Full Text View

A Laboratory Model for Heroin Abuse Medications - 8

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) New York State Psychiatric Institute
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000273

Purpose

The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."

Condition	Intervention	Phase
Heroin Dependence Opioid-Related Disorders Substance-Related Disorders	Drug: Methadone	Phase II

MedlinePlus related topics:

Heroin

ChemIDplus related topics:

Methadone Methadone hydrochloride Diacetylmorphine Diacetylmorphine hydrochloride

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Official Title:	A Laboratory Model for Heroin Abuse Medications

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Amount heroin self-administered
Direct opiate effects
Opiate withdrawal
Physiological measures
Task performance

Estimated Enrollment:	37
Study Start Date:	August 1995

Eligibility

Ages Eligible for Study:	18 Years to 45 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000273

Locations


United States, New York
	Columbia University
	New York, New York, United States, 10023

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

New York State Psychiatric Institute

Investigators


Principal Investigator:	Herbert Kleber, M.D.	New York State Psychiatric Institute

More Information

Study ID Numbers:	NIDA-09236-8, P50-09236-8
First Received:	September 20, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00000273
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Methadone

Heroin

Mental Disorders

Heroin Dependence

Substance-Related Disorders

Disorders of Environmental Origin

Opioid-Related Disorders

Additional relevant MeSH terms:

Pathologic Processes

Disease

ClinicalTrials.gov processed this record on September 05, 2008